GSC
RLYB icon

Ground Swell Capital’s Rallybio RLYB Stock Holding History

Ground Swell Capital’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,925
Closed -$10.6K – 166
2025
Q4 		$10.6K Buy
+1,925
New +$9.91K 0.02% 73

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Ground Swell Capital's RLYB Position: Q1 2026 in Review

Ground Swell Capital sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 1,925 shares — an estimated $10.6K sold.

Ground Swell Capital first reported a position in RLYB in Q4 2025 and held it in 1 quarter. The position peaked at $10.6K in Q4 2025. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Ground Swell Capital reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • Ground Swell Capital sold 1,925 Rallybio shares in Q1 2026, an estimated $10.6K.
  • Ground Swell Capital first reported a position in Rallybio in Q4 2025 and held it in 1 quarter.
  • Ground Swell Capital's Rallybio position peaked at $10.6K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Ground Swell Capital's 13F filing for Q1 2026, filed 21 Apr 2026.